| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2024 ( Subtotal = $650,000 ) |
| | 2024 | 2024 | ALBERT B. SABIN VACCINE INSTITUTE, INC. (THE) | 2000 PENNSYLVANIA AVE NW STE 7000 | WASHINGTON | DC | 20006-1921 | DISTRICT OF COLUMBIA | USA | NU66GH002177 | Strengthening Immunization Program Implementation in Consequential Sub-National Geographical Areas of Brazil | 00 | 1 | CDC | 9/3/2024 | $650,000 |
|
| Issue Date FY: 2020 ( Subtotal = -$153,335 ) |
| | 2020 | 2017 | Albert B. Sabin Vaccine Institute, Inc. (the) | 2175 K Street NW Suite 400 | Washington | DC | 20037-1848 | DISTRICT OF COLUMBIA | USA | NU66GH002168 | Economics, finance, and budgetary evidence to support sustainable financing, planning and decision-m | 03 | 2 | CDC | 12/13/2019 | -$153,335 |
| | 2020 | 2016 | Albert B. Sabin Vaccine Institute, Inc. (the) | 2175 K Street NW Suite 400 | Washington | DC | 20037-1848 | DISTRICT OF COLUMBIA | USA | NU66GH002168 | Economics, finance, and budgetary evidence to support sustainable financing, planning and decision-m | 03 | 2 | CDC | 12/13/2019 | $0 |
| | 2020 | 2016 | Albert B. Sabin Vaccine Institute, Inc. (the) | 2175 K Street NW Suite 400 | Washington | DC | 20037-1848 | DISTRICT OF COLUMBIA | USA | NU66GH002168 | Economics, finance, and budgetary evidence to support sustainable financing, planning and decision-m | 03 | 2 | CDC | 12/13/2019 | $0 |
|
| Issue Date FY: 2018 ( Subtotal = $0 ) |
| | 2018 | 2017 | Albert B. Sabin Vaccine Institute, Inc. (The) | 2175 K Street NW Suite 400 | Washington | DC | 20037-1848 | DISTRICT OF COLUMBIA | USA | NU66GH002168 | Economics, finance, and budgetary evidence to support sustainable financing, planning and decision-m | 01 | 2 | CDC | 2/12/2018 | $0 |
| | 2018 | 2017 | Albert B. Sabin Vaccine Institute, Inc. (The) | 2175 K Street NW Suite 400 | Washington | DC | 20037-1848 | DISTRICT OF COLUMBIA | USA | NU66GH002168 | Economics, finance, and budgetary evidence to support sustainable financing, planning and decision-m | 02 | 2 | CDC | 6/19/2018 | $0 |
|
| Issue Date FY: 2017 ( Subtotal = $645,756 ) |
| | 2017 | 2017 | Albert B. Sabin Vaccine Institute, Inc. (The) | 2175 K Street NW Suite 400 | WASHINGTON | DC | 20037-1848 | DISTRICT OF COLUMBIA | USA | NU66GH002168 | Economics, finance, and budgetary evidence to support sustainable financing, planning and decision-m | 02 | 1 | CDC | 3/6/2017 | $117,081 |
| | 2017 | 2017 | Albert B. Sabin Vaccine Institute, Inc. (The) | 2175 K Street NW Suite 400 | WASHINGTON | DC | 20037-1848 | DISTRICT OF COLUMBIA | USA | NU66GH002168 | Economics, finance, and budgetary evidence to support sustainable financing, planning and decision-m | 00 | 2 | CDC | 6/20/2017 | $528,675 |
|
| Issue Date FY: 2016 ( Subtotal = $468,328 ) |
| | 2016 | 2016 | ALBERT B SABIN VACCINE INSTITUTE | 161 CHERRY STREET | NEW CANAAN | CT | 06840 | WESTERN CT | USA | NU66GH002168 | Economics, finance, and budgetary evidence to support sustainable financing, planning and decision-m | 00 | 1 | CDC | 7/20/2016 | $14,500 |
| | 2016 | 2016 | ALBERT B SABIN VACCINE INSTITUTE | 161 CHERRY STREET | NEW CANAAN | CT | 06840 | WESTERN CT | USA | NU66GH002168 | Economics, finance, and budgetary evidence to support sustainable financing, planning and decision-m | 00 | 1 | CDC | 7/20/2016 | $453,828 |
|
| Issue Date FY: 2013 ( Subtotal = $0 ) |
| | 2013 | 2011 | ALBERT B SABIN VACCINE INSTITUTE | 161 CHERRY STREET | NEW CANAAN | CT | 06840 | WESTERN CT | USA | R56AI090577 | PRODUCT DEVELOPMENT OF A MEMBRANE TETRASPANIN VACCINE AGAINST SCHISTOSOMIASIS | 000 | 1 | NIH | 2/19/2013 | $0 |
|
| Issue Date FY: 2011 ( Subtotal = $561,750 ) |
| | 2011 | 2011 | ALBERT B SABIN VACCINE INSTITUTE | 161 CHERRY STREET | NEW CANAAN | CT | 06840 | WESTERN CT | USA | R56AI090577 | PRODUCT DEVELOPMENT OF A MEMBRANE TETRASPANIN VACCINE AGAINST SCHISTOSOMIASIS | 000 | 1 | NIH | 1/2/2011 | $561,750 |
|
| Issue Date FY: 2005 ( Subtotal = $9,000 ) |
| | 2005 | 2005 | ALBERT B SABIN VACCINE INSTITUTE | 161 CHERRY STREET | NEW CANAAN | CT | 06840 | WESTERN CT | USA | R13CA117408 | ANNUAL SABIN COLLOQUIUM ON CANCER VACCINES AND IMMUNOTHERAPY | 000 | 1 | NIH | 6/10/2005 | $9,000 |
|
|
